Want to see IN:VISHNU full AI Analyst Report?
VISHNU Stock Chart & Stats
₹636.60
-₹16.00(-2.51%)
At close: 4:00 PM EDT
₹636.60
-₹16.00(-2.51%)
Day’s Range― - ―
52-Week Range₹444.25 - ₹722.45
Previous CloseN/A
Volume74.28K
Average Volume (3M)8.13K
Market Cap
₹47.24B
Enterprise Value₹37.16K
Total Cash (Recent Filing)₹1.00B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)31.4
Beta0.58
Next Earnings
Oct 29, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.04%
Share Statistics
EPS (TTM)22.29
Shares Outstanding67,315,285
10 Day Avg. Volume14,054
30 Day Avg. Volume8,133
Financial Highlights & Ratios
PEG Ratio2.33
Price to Book (P/B)3.08
Price to Sales (P/S)2.04
P/FCF Ratio-20.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)27.5
Revenue Forecast (FY)₹17.92B
Bulls Say, Bears Say
Bulls Say
Specialty Chemicals FocusA focused portfolio of chromium-based specialty chemicals gives the company established exposure to industrial customers and defined end-use applications. Product specifications, quality consistency, and reliable supply can support repeat orders and provide a foundation for durable customer relationships.
Revenue And Profitability RecoveryPositive revenue growth after the prior decline, together with healthy operating margins, indicates that the business has regained momentum while retaining meaningful operating profitability. This recovery can support reinvestment and strengthen earnings capacity over the next several quarters if growth continues.
Improved LeverageThe substantial reduction in debt-to-equity shows that the balance sheet is stronger than during earlier high-leverage periods. Greater equity support and moderate current leverage improve resilience and provide more financial flexibility, even though debt levels still require monitoring.
Bears Say
Persistent Negative Free Cash FlowSustained negative free cash flow means reported profits are not translating into internally available funds, potentially reflecting heavy investment or working-capital needs. If this persists, the company may rely more on debt or other funding, reducing flexibility to pursue growth.
Margin CompressionThe pronounced decline in gross margin indicates that earlier profitability levels have not been maintained. Higher input costs, pricing pressure, or product-mix changes could continue to limit earnings expansion unless operating margins stabilize and the company preserves its spread.
Recent Debt Increase And Lower ReturnsThe recent increase in absolute debt is a concern because cash generation is already weak, potentially narrowing financial flexibility if funding needs continue. At the same time, lower return on equity suggests capital is generating less profit than in the unusually strong FY2023 period.
Vishnu Chemicals Limited News
VISHNU FAQ
What was Vishnu Chemicals Limited’s price range in the past 12 months?
Vishnu Chemicals Limited lowest stock price was ₹444.25 and its highest was ₹722.45 in the past 12 months.
What is Vishnu Chemicals Limited’s market cap?
Vishnu Chemicals Limited’s market cap is ₹47.24B.
When is Vishnu Chemicals Limited’s upcoming earnings report date?
Vishnu Chemicals Limited’s upcoming earnings report date is Oct 29, 2026 which is in 52 days.
How were Vishnu Chemicals Limited’s earnings last quarter?
Vishnu Chemicals Limited released its earnings results on Aug 01, 2026. The company reported ₹5.889 earnings per share for the quarter.
Is Vishnu Chemicals Limited overvalued?
According to Wall Street analysts Vishnu Chemicals Limited’s price is currently Overvalued.
Does Vishnu Chemicals Limited pay dividends?
Vishnu Chemicals Limited pays a Annually dividend of ₹0.3 which represents an annual dividend yield of 0.04%. See more information on Vishnu Chemicals Limited dividends here
What is Vishnu Chemicals Limited’s EPS estimate?
Vishnu Chemicals Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Vishnu Chemicals Limited have?
Vishnu Chemicals Limited has 67,315,285 shares outstanding.
What happened to Vishnu Chemicals Limited’s price movement after its last earnings report?
Vishnu Chemicals Limited reported an EPS of ₹5.889 in its last earnings report. Following the earnings report the stock price went down -0.69%.
Which hedge fund is a major shareholder of Vishnu Chemicals Limited?
Currently, no hedge funds are holding shares in IN:VISHNU
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Vishnu Chemicals Limited
Founded in 1989 and headquartered in Hyderabad, India, Vishnu Chemicals Limited specializes in the manufacturing and global distribution of chromium and barium compounds. The company's extensive product line features various chrome-based chemicals, including sodium dichromate, chromic acid, chrome oxide green, basic chromium sulfate, sodium sulfate, and potassium dichromate, alongside barium carbonate. These essential chemicals serve a broad spectrum of industries, finding critical applications in pharmaceuticals, pigments, sports surfacing, leather processing, construction materials (such as equipment, roofing, and ceramic tiles), the automotive sector, decorative and functional plating, detergents, textiles, refractory brick production, and timber preservation. With its operational base in India, Vishnu Chemicals maintains a significant international footprint, supplying its offerings across Asia (including China and Southeast Asia), Europe (encompassing the United Kingdom), North America, South and Central America, Africa, and other worldwide markets.
Technical Analysis
Fineotex Chemical Limited
―
Laxmi Organic Industries Ltd.
―
Neogen Chemicals Ltd.
―
Rossari Biotech Ltd
―
Tatva Chintan Pharma Chem Limited
―